Roberto Bellini , President and Chief Executive Officer

Roberto Bellini has served as President and CEO of BELLUS Health since January 1, 2010.

Mr. Bellini previously oversaw the licensing and partnering activities of BELLUS Health Inc. His experience includes responsibility for the investment and operational activities of Picchio Pharma Inc., a joint venture healthcare investment firm owned by FMRC Family Trust and Power Technology Investment Corporation.

Mr. Bellini is a sitting member of the Board of Directors of BELLUS Health.

He has broad ties in the community and has served on numerous fundraising committees for the following institutions: l’Institut du cancer de Montréal, the Sarah Cook Fund for the Cedars Cancer Institute, l’Institut de Gériatrie, le Musée d’art contemporain de Montréal and la Fondation Quebec Jeunes.

Mr. Bellini holds a Bachelor of Science in Biochemistry from McGill University.

Dr. Denis Garceau , Senior Vice President, Drug Development

Dr. Denis Garceau directs BELLUS Health's drug development program, from toxicology to clinical evaluation through to approval of new products, and has been with the Company since March 1997. He is also currently the Auven Therapeutics Global Project Leader for the Kiacta™ development program.

From 1986 to 1997, as a clinical scientist and product team leader for Hoechst Marion Roussel (now Sanofi-Aventis), Dr. Garceau successfully oversaw North American clinical programs and participated in global clinical development steering committees. He was responsible for developing clinical operating plans, designing clinical protocols, and supervising clinical trials. In 1985-86, Dr. Garceau completed a post-doctorate Research fellowship in Pharmacology at Merck Frosst Canada.

Dr. Garceau holds a Ph.D. in Pharmacology from the Université de Montréal, and is currently a guest lecturer for the faculty of pharmacy of the Université de Montréal and Université Laval.

François Desjardins , Vice President, Finance

François Desjardins is responsible for BELLUS Health’s finance and administration functions. He joined the Company in 2003 as Director, Finance and Control and holds the position of Vice-president, Finance since 2009.

Mr. Desjardins has over 20 years of experience in the biopharmaceutical industry, having held the position of Corporate Controller at BioChem Pharma for a period of six years.

He is a member of the Ordre des comptables professionnels agréés du Québec (OCPAQ) and holds a Bachelor Degree of Commerce from Sherbrooke University.

Tony Matzouranis , Vice President, Business Development

Tony Matzouranis joined BELLUS Health in 2010 and currently oversees the Company’s licensing and business development activities.

He has over 15 years of experience in structuring and building successful partnerships via in / out-licensing, mergers and acquisitions and alliance management. Prior to joining BELLUS Health, Mr. Matzouranis was Director of Licensing at Thallion Pharmaceuticals. From 1999 to 2007, he held Business Development positions of increasing responsibility at Caprion Pharmaceuticals.

Mr. Matzouranis holds a Master’s degree in Molecular Biology from the Université du Québec à Montréal.

Share this

Sign up for email alerts

Email Address *
 
Enter the code shown above.